Can Subsense’s Nanoparticles Be One Small Step for BCI?
Tetiana Aleksandrova on how Subsense is using nanoparticles to establish brain-computer interfaces with the potential to deliver new therapies.| DeviceTalks
In this episode of DeviceTalks Weekly, Editorial Director Tom Salemi sits down with Ken Charhut, executive chair and CEO of Foldax, to discuss how the startup’s polymer valve and robotic manufacturing process could offer a new alternative to traditional structural […] The post Can Foldax’s Polymer, Robots Upend Heart Valve Market? NVIDIA’s Niewolny Talks Digital Surgery appeared first on DeviceTalks.| DeviceTalks
In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the […] The post Why Abbott’s vascular team sees AI as the GPS for the cath lab appeared first on DeviceTalks.| DeviceTalks
Tetiana Aleksandrova on how Subsense is using nanoparticles to establish brain-computer interfaces with the potential to deliver new therapies.| DeviceTalks
Peter Menziuso, J&J company group chair, Vision on the company’s strategy to advance vision care; Boston Scientific's Dennis Cheng on AI & Dx.| DeviceTalks
CEO Ken Mariash shares how Sinaptica Therapeutics, a neuromod company developing a TMS system, may be able to slow the advance of Alzheimer’s| DeviceTalks
Solventum's Rachel Ellingson shares a rare perspective on leading MedTech companies through major transitions, and outlines what’s ahead.| DeviceTalks
Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since 2021.| DeviceTalks
